Table 2.
PI-NRS of the Participants During Study Duration
| Treatment [Mean (SD)] | IP (n=27) | p-value# | Placebo (n=32) | p-value# | p-value* |
|---|---|---|---|---|---|
| Day 0 | 7.81 (1.04) | 7.88 (1.04) | 0.98 | ||
| Day 7 | 6.89 (1.37) | <0.0001 | 7.81 (0.93) | 0.6875 | 0.006 |
| Day 28 | 4.78 (1.40) | <0.0001 | 7.81 (1.18) | 0.8331 | <0.0001 |
| Day 42 | 3.04 (1.68) | <0.0001 | 8.03 (1.06) | 0.3593 | <0.0001 |
Notes: *Between-group p-value was calculated using Mann Whitney U-test. #Within-group p-value was compared with baseline and calculated using Wilcoxon Signed Rank test (W).